OPKO Health (LTS:0KCS) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 11, 2026)


LTS:0KCS OPKO Health Inc LTS:0KCS
57 GF Score
Price $1.35
GF Value $1.06
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is OPKO Health 5-Year Yield-on-Cost %?

OPKO Health LTS:0KCS -2.88% 57 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus rates LTS:0KCS with a GF Score™ of 57/100 and a GF Value™ of $1.06 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, OPKO Health ranks worse than 1538460% on this metric.

OPKO Health's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for OPKO Health's 5-Year Yield-on-Cost % or its related term are showing as below:



LTS:0KCS's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.45
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

OPKO Health  (LTS:0KCS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


OPKO Health 5-Year Yield-on-Cost % Related Terms


LTS:0KCS vs PSNL, CDNA, CSTL: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, OPKO Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OPKO Health 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, OPKO Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where OPKO Health's 5-Year Yield-on-Cost % falls into.


LTS:0KCS
57GF Score
OPKO Health Inc LTS:0KCS
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OPKO Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of OPKO Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
OPKO Health (LTS:0KCS) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OPKO Health and its competitors. According to the industry distribution chart, OPKO Health ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry.
Is OPKO Health's 5-Year Yield-on-Cost % too high?
OPKO Health's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, OPKO Health ranks #999999 out of 65 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, OPKO Health has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's 5-Year Yield-on-Cost % compare to PSNL and CDNA?
According to the Medical Diagnostics & Research industry distribution chart, OPKO Health ranks #999999 out of 65 companies for 5-Year Yield-on-Cost %. This places OPKO Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.45, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on OPKO Health and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OPKO Health's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.35 — trading 27.4% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. OPKO Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (LTS:0KCS) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of $1.35 is trading 27.4% above its estimated GF Value™ of $1.06. GuruFocus considers OPKO Health to be Modestly Overvalued.

Key valuation signals for LTS:0KCS:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $1.06 vs. price of $1.35 (27.4% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
57GF Score

Get the complete analysis for LTS:0KCS

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.35
Price
$1.06
GF Value